Improving timely identification and referral of patients who may be eligible for chimeric antigen receptor (CAR) T-cell therapy is critical for improving outcomes for patients with hematologic malignancies. On February 7, 2024, ACCC hosted a virtual Working Summit: Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education to explore topics including patient and caregiver needs as well as care coordination between referring providers and certified CAR T-cell therapy centers.
In this episode, CANCER BUZZ speaks with Amy D. Smith, FNP-BC, director of the Meredith and Jeannie Ray Cancer Center at Ivinson Memorial Hospital and co-chair of the Summit about the event’s key findings, which can guide cancer programs in building a framework for optimized CAR T-cell therapy care coordination.
“The goal really was how do we get those patients [receiving CAR T-cell therapy] back here and get them back into some kind of normalcy in their life sooner? A lot of that is building relationships and having trust with those providers in the academic centers that are performing the CAR T, so that they know that we can provide safe care at home.” –Amy D. Smith, FNP-BC
“Keeping care close to home is near to my heart, living in a rural area. That was one takeaway... how do we collaborate better to make this happen for our patients and care teams? –Amy D. Smith, FNP-BC
Amy D. Smith, FNP-BC
Director, Meredith and Jeannie Ray Cancer Center
Ivinson Memorial Hospital
Laramie, WY
This episode was developed in connection with the ACCC education program Tips for Early Patient Identification for CAR T-Cell Therapy and Care Continuity with Community Providers and made possible with support by Kite Pharma, Johnson & Johnson, and Legend Biotech, and through partnerships with Cancer Support Community, the Association of American Cancer Institutes, and the Advanced Practitioner Society for Hematology and Oncology.
Resources:
The Florez Lab: Increasing Retention and Improving Productivity of Under-Represented in Medicine Trainees
BRCA Testing Survey Insights: A Multidisciplinary Perspective on Testing and Treatment for Patients with Breast Cancer
Championing an Institutional Culture of Well-being in a Post-Pandemic Oncology Workforce
Missed Care Conversations for Patients with DLBCL
Community CAR T-Cell Patient Identification Framework
The Future of the Patient Experience
Highlights from the ACCC Working Summit: Biomarker Testing – Solutions for EHR Integration
Developing a Disease-Site Specific Oncology Patient Navigation Program
Germline and Somatic Testing for Ovarian Cancer
AML Care Coordination in the Community Setting
Live from NOC: AI in Precision Oncology
Live from NOC: Technology Support for Health Care Workforce
Live from NOC: ACCC Priorities for the President’s Cancer Panel
Live from NOC: Recruiting Strategies
Live from NOC: Leadership for Challenging Times
Live from NOC: Rural Appalachian Lung Screening Initiative
NOC Preview: Biomarker Testing for Medicaid Beneficiaries
NOC Preview: Financial Advocacy Guidelines to Mitigate Financial Toxicity
Examining Shared Decision-Making in Bladder Cancer Care
Importance of Clinical Team to Recognize SCLC
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain